BIOMERICA INC (BMRA)

↓ Download CSV

CIK 0000073290 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends May 31

In fiscal 2026, BIOMERICA INC reported revenue of $4.45M, down 16.2% from the prior year. The company ran a net loss, with a net margin of -84.8% and a gross margin of 8.1%. It held $6.76M in total assets against $4.13M in total liabilities.

Key ratios (FY2026)

8.1%
Gross margin
-119.5%
Operating margin
-84.8%
Net margin
-143.5%
Return on equity
-16.2%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020201920182017
Revenue$4.45M$5.31M$5.42M$5.34M$18.87M$7.20M$6.69M$5.20M$5.56M$5.79M
Cost of Revenue$4.09M$4.81M$4.80M$4.89M$15.89M$6.83M$4.95M$3.91M$3.81M$3.77M
Gross Profit$362.0K$498.0K$611.0K$446.0K$2.98M$366.3K$1.74M$1.29M$1.75M$2.02M
Operating Income-$5.32M-$5.14M-$6.37M-$7.22M-$4.53M-$7.50M-$2.74M-$2.41M-$1.48M-$954.6K
Net Income-$3.77M-$4.97M-$5.98M-$7.14M-$4.53M-$7.45M-$2.68M-$2.39M-$1.47M-$908.6K
EPS (Diluted)$-1.30$-2.16$-2.84$-0.50$-0.36$-0.62$-0.26$-0.26$-0.17$-0.11
Total Assets$6.76M$5.95M$9.25M$14.45M$11.37M$11.82M$17.26M$5.25M$5.22M$5.02M
Total Liabilities$4.13M$1.84M$2.66M$2.73M$3.05M$2.59M$3.05M$1.26M
Shareholders' Equity$2.63M$4.11M$6.59M$11.72M$8.32M$9.23M$14.21M$3.98M$4.33M$4.49M
Cash & Equivalents$1.31M$2.40M$4.17M$9.72M$5.92M$4.20M$8.64M$686.8K$1.20M$1.23M
Operating Cash Flow-$3.42M-$3.84M-$5.36M-$5.47M-$479.0K-$5.25M-$4.30M-$2.24M-$1.17M-$722.9K
Capital Expenditures$51.0K$64.0K$57.0K$135.9K$33.6K$101.1K$130.3K$96.1K
Shares Outstanding3.20M2.55M2.10M16.82M12.87M12.31M11.74M9.68M8.89M8.51M